Who Paid My Doc
ClosureFast
Device EndoVenous Therapies
PDI 00643169862982
General payments
$462,266
Research payments
$51,306
Through program year 2025, $462,266 in general payments and $51,306 in research payments were reported against ClosureFast (EndoVenous Therapies).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $96,523 | 837 |
| 2024 | General | $66,283 | 1,035 |
| 2024 | Research | $51,306 | 3 |
| 2023 | General | $75,021 | 1,241 |
| 2022 | General | $107,276 | 1,206 |
| 2021 | General | $117,164 | 1,071 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 58 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
5,390 general · 3 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.